Cancer Tissue Gallery- GTX648266

Breast – CLDN18.2 negative invasive breast cancer of no special type (NST).

Breast – CLDN18.2 negative invasive lobular breast cancer.

Colon – CLDN18.2 negative colorectal adenocarcinoma.

Colon – CLDN18.2 negative colorectal adenocarcinoma.

Kidney – CLDN18.2 negative clear cell carcinoma.

Kidney – CLDN18.2 negative oncocytoma.

Kidney – CLDN18.2 negative papillary renal cell carcinoma.

Lung – CLDN18.2 negative malignant mesothelioma (epitheloid).

Lung – CLDN18.2 negative squamous cell carcinoma.

Oral cavity – CLDN18.2 negative squamous cell carcinoma.

Ovary – CLDN18.2 negative clear cell carcinoma.

Ovary – CLDN18.2 negative endometroid carcinoma.

Ovary – CLDN18.2 negative serous high-grade carcinoma.

Pancreas – Ductal adenocarcinoma with distinct membranous CLDN18.2 staining of most tumor cells.

Pancreas – Ductal adenocarcinoma with strong CLDN18.2 staining of tumor cells.

Pancreas – Ductal adenocarcinoma with strong membranous CLDN18.2 staining of all tumor cells.

Pancreas – Ductal adenocarcinoma with strong membranous CLDN18.2 staining of most tumor cells.

Pharynx – CLDN18.2 negative squamous cell carcinoma.

Prostate – CLDN18.2 negative adenocarcinoma (Gleason 3+3=6).

Prostate – CLDN18.2 negative adenocarcinoma (Gleason 4+4=8).

Stomach – Gastric adenocarcinoma (intestinal type) with strong membranous CLDN18.2 positivity of all tumor cells.

Stomach – Gastric adenocarcinoma (intestinal type) with strong membranous CLDN18.2 positivity of tumor cells.

Stomach – Gastric adenocarcinoma (diffuse type) with strong membranous CLDN18.2 staining of most tumor cells.

Testis – CLDN18.2 negative seminoma.

Thyroid – CLDN18.2 negative papillary carcinoma.

Urinary bladder – CLDN18.2 negative muscle-invasive urothelial carcinoma.

Urinary bladder – CLDN18.2 negative non-invasive papillary urothelial carcinoma (pTa).